Chapter 7. Hypertrophic Cardiomyopathy and other Forms of Hypertrophy

  1. Dan Roden MD Professor Director Assistant Vice-Chancellor
  1. Carolyn Y. Ho MD Assistant Professor

Published Online: 27 APR 2009

DOI: 10.1002/9781444311785.ch7

Cardiovascular Genetics and Genomics

Cardiovascular Genetics and Genomics

How to Cite

Ho, C. Y. (2009) Hypertrophic Cardiomyopathy and other Forms of Hypertrophy, in Cardiovascular Genetics and Genomics (ed D. Roden), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444311785.ch7

Editor Information

  1. Oates Institute for Experimental Therapeutics, Personalized Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA

Author Information

  1. Haward Medical School, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA

Publication History

  1. Published Online: 27 APR 2009
  2. Published Print: 17 APR 2009

Book Series:

  1. The AHA Clinical Series

Book Series Editors:

  1. Elliott Antman

ISBN Information

Print ISBN: 9781405175401

Online ISBN: 9781444311785



  • hypertrophic cardiomyopathy;
  • left ventricular hypertrophy (LVH);
  • myocyte hypertrophy;
  • asymmetric septal hypertrophy;
  • disopyramide;
  • implantable cardioverter defibrillator (ICD) therapy;
  • myosin heavy chains (MHCs);
  • genotype–phenotype correlations;
  • diastolic dysfunction


This chapter contains sections titled:

  • Introduction

  • Hypertrophic cardiomyopathy: a disease of the sarcomere

  • Other paradigms of genetic cardiac hypertrophy

  • From bench to bedside: integrating genetic information into clinical practice

  • Conclusions

  • References